Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 1
1973 1
1974 1
1975 1
1976 3
1978 3
1979 2
1980 1
1981 3
1982 4
1984 3
1985 4
1986 4
1987 8
1988 5
1989 7
1990 7
1991 10
1992 12
1993 11
1994 13
1995 22
1996 16
1997 17
1998 24
1999 30
2000 28
2001 20
2002 19
2003 13
2004 24
2005 27
2006 18
2007 22
2008 37
2009 24
2010 35
2011 48
2012 54
2013 45
2014 49
2015 50
2016 55
2017 71
2018 60
2019 74
2020 64
2021 34
2022 10
2023 11
2024 75
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial, Systematic Review, in the last 1 year, Child: birth-18 years, Infant: birth-23 months, Newborn: birth-1 month, Infant: 1-23 months, Preschool Child: 2-5 years, Child: 6-12 years, Adolescent: 13-18 years. Clear all
Page 1
Extended optical treatment versus early patching with an intensive patching regimen in children with amblyopia in Europe (EuPatch): a multicentre, randomised controlled trial.
Proudlock FA, Hisaund M, Maconachie G, Papageorgiou E, Manouchehrinia A, Dahlmann-Noor A, Khandelwal P, Self J, Beisse C, Gottlob I; EUPatch study group. Proudlock FA, et al. Lancet. 2024 May 4;403(10438):1766-1778. doi: 10.1016/S0140-6736(23)02893-3. Lancet. 2024. PMID: 38704172 Free article. Clinical Trial.
Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia.
Writing Committee for the Pediatric Eye Disease Investigator Group; Pediatric Eye Disease Investigator Group; Chen AM, Erzurum SA, Chandler DL, Hercinovic A, Wu R, Vricella M, Waters AL, Ticho BH, Erickson JW, Han S, McDowell PS, Li Z, Kraker RT, Holmes JM, Cotter SA. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. JAMA Ophthalmol. 2024 May 1;142(5):417-428. doi: 10.1001/jamaophthalmol.2024.0276. JAMA Ophthalmol. 2024. PMID: 38536764 Clinical Trial.
Control of myopia using diffusion optics spectacle lenses: 4-year results of a multicentre randomised controlled, efficacy and safety study (CYPRESS).
Laughton D, Hill JS, McParland M, Tasso V, Woods J, Zhu X, Young G, Craven R, Hunt C, Neitz J, Neitz M, Chalberg TW, Jones D, Wolffsohn JS. Laughton D, et al. BMJ Open Ophthalmol. 2024 Oct 9;9(1):e001790. doi: 10.1136/bmjophth-2024-001790. BMJ Open Ophthalmol. 2024. PMID: 39384223 Free PMC article. Clinical Trial.
Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis Pigmentosa.
Michaelides M, Besirli CG, Yang Y, DE Guimaraes TAC, Wong SC, Huckfeldt RM, Comander JI, Sahel JA, Shah SM, Tee JJL, Kumaran N, Georgiadis A, Minnick P, Zeldin R, Naylor S, Xu J, Clark M, Anglade E, Wong P, Fleck PR, Fung A, Peluso C, Kalitzeos A, Georgiou M, Ripamonti C, Smith AJ, Ali RR, Forbes A, Bainbridge J. Michaelides M, et al. Am J Ophthalmol. 2024 Nov;267:122-134. doi: 10.1016/j.ajo.2024.05.034. Epub 2024 Jun 12. Am J Ophthalmol. 2024. PMID: 38871269 Free article. Clinical Trial.
Binocular Home Treatment for Amblyopia: Gains Stable for One Year.
Wygnanski-Jaffe T, Moshkovitz A, Kushner BJ, Belkin M, Yehezkel O; CureSight Pivotal Trial Group. Wygnanski-Jaffe T, et al. Am J Ophthalmol. 2024 Jun;262:199-205. doi: 10.1016/j.ajo.2024.02.004. Epub 2024 Feb 14. Am J Ophthalmol. 2024. PMID: 38360334 Free article. Clinical Trial.
Baseline factors associated with myopia progression and axial elongation over 30 months in children 5 to 12 years of age.
Weise KK, Repka MX, Zhu Y, Manny RE, Raghuram A, Chandler DL, Summers AI, Lee KA, Kehler LAF, Pang Y, Allen MS, Anderson HA, Erzurum SA, Golden RP, Koutnik CA, Kuo AF, Lenhart PD, Mokka PL, Petersen DB, Ticho BH, Wiecek EK, Yin H, Beaulieu WT, Kraker RT, Holmes JM, Cotter SA; Pediatric Eye Disease Investigator Group. Weise KK, et al. Optom Vis Sci. 2024 Oct 1;101(10):619-626. doi: 10.1097/OPX.0000000000002187. Optom Vis Sci. 2024. PMID: 39480129 Clinical Trial.
Feasibility of a new 'balanced binocular viewing' treatment for unilateral amblyopia in children aged 3-8 years (BALANCE): results of a phase 2a randomised controlled feasibility trial.
Dahlmann-Noor AH, Greenwood JA, Skilton A, Baker D, Abbas M, Clay E, Khandelwal P, Dunham D, Ludden S, Davis A, Dehbi HM, Dakin SC. Dahlmann-Noor AH, et al. BMJ Open. 2024 Jul 30;14(7):e082472. doi: 10.1136/bmjopen-2023-082472. BMJ Open. 2024. PMID: 39079927 Free PMC article. Clinical Trial.
One-year follow-up of clinical convergence measures in children enrolled in the Convergence Insufficiency Treatment Trial-Attention and Reading Trial.
Morrison AM, Kulp MT, Cotter SA, Scheiman MM, Jenewein EC, Roberts TL, Mitchell GL, Arnold LE, Retnasothi D, Bade A, Hertle R, Borsting E; Convergence Insufficiency Treatment Trial—Attention and Reading (CITT‐ART) Investigator Group. Morrison AM, et al. Ophthalmic Physiol Opt. 2024 Nov;44(7):1346-1353. doi: 10.1111/opo.13378. Epub 2024 Aug 14. Ophthalmic Physiol Opt. 2024. PMID: 39141379 Clinical Trial.